CVS Caremark Corp. has named Dr. William Shrank chief scientific officer and chief medical officer for provider innovation and analytics.


CVS Caremark, William Shrank, chief scientific officer, chief medical officer, provider innovation and analytics, research and clinical program development, pharmacy benefit, pharmaceutical outcomes research, medication adherence, Troyen Brennan, Brigham Internal Medicine Associates, Harvard Medical School, Center for Medicare and Medicaid Innovation
































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Inside This Issue - News

Shrank to head research at CVS Caremark

November 25th, 2013

WOONSOCKET, R.I. – CVS Caremark Corp. has named Dr. William Shrank chief scientific officer and chief medical officer for provider innovation and analytics.

Shrank will focus on developing pharmacy solutions aimed at improving quality of care while lowering costs to help health care providers deliver services to distinct patient populations.

He will also oversee the company’s research and clinical program development with the goal of delivering new methods of evaluating programs and ­initiatives.

Shrank has extensive experience in pharmaceutical outcomes research and has published on topics including the evaluation of various pharmacy benefit designs, the Medicare Part D Prescription drug benefit, medication adherence for chronic conditions and ensuring high-quality patient communications regarding the risks and benefits of prescribed ­medications.

Before joining CVS, he was a physician with Brigham Internal Medicine Associates and an assistant professor at Harvard Medical School. Earlier, he was director of research and rapid-cycle evaluation for the Center for Medicare and Medicaid Innovation at the Centers for Medicare and Medicaid Services.

“Will’s depth of experience as a researcher makes him uniquely qualified to oversee our research agenda,” said CVS chief medical officer Dr. Troyen Brennan. “His insights and expertise will enable us to continue to develop new solutions to improve care and quality for patients dealing with chronic disease.”

Shrank says he will work to expand the company’s research efforts.

“CVS Caremark has built a strong reputation as a leader in medication adherence research, and we look forward to expanding upon this focus,” he said.

Advertisement